獐子岛(002069) - 2025 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2025 was ¥410,064,335.30, representing an increase of 11.13% compared to ¥369,003,989.45 in the same period last year[5] - The net profit attributable to shareholders was a loss of ¥1,561,337.43, an improvement of 77.73% from a loss of ¥7,011,978.43 in the previous year[5] - The basic earnings per share improved to -¥0.0022, a 77.78% increase from -¥0.0099 in the same period last year[5] - Net profit for the current period was -¥2,648,763.75, an improvement from -¥8,644,214.81 in the previous period, indicating a reduction in losses[18] - The company reported a total comprehensive loss of -¥3,052,216.06, compared to -¥12,180,681.56 in the previous period, showing a decrease in overall losses[18] Cash Flow and Liquidity - The net cash flow from operating activities was negative at ¥3,553,117.52, a decline of 115.24% compared to a positive cash flow of ¥23,317,255.01 in the same period last year[5] - Cash and cash equivalents at the end of the period totaled ¥576,160,717.14, down from ¥591,561,819.81 at the end of the previous period[20] - The company's cash and cash equivalents decreased from 603,836,715.76 yuan to 584,014,157.02 yuan, a decline of about 3.06%[15] Assets and Liabilities - The total assets at the end of the reporting period were ¥2,217,797,736.61, down 2.27% from ¥2,269,225,746.89 at the end of the previous year[5] - Current assets decreased from 1,567,670,103.32 yuan to 1,535,324,442.33 yuan, a decline of about 2.06%[15] - Total liabilities decreased from 2,172,945,394.63 yuan to 2,124,569,600.41 yuan, a decrease of approximately 2.22%[16] - The company's total liabilities and equity amounted to ¥2,217,797,736.61, a decrease from ¥2,269,225,746.89 in the previous period[17] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 32,439[10] - As of the end of the reporting period, Dalian Salt Chemical Group Co., Ltd. holds 109,960,000 shares, accounting for 15.4631% of the total share capital of the company[12] - The equity attributable to shareholders decreased by 3.88% to ¥49,683,006.87 from ¥51,690,461.35 at the end of the previous year[5] Operating Costs and Expenses - Total operating costs amounted to ¥412,760,959.73, up from ¥383,023,036.30, reflecting a rise of 7.8%[17] - The company reported a 42.88% decrease in financial expenses, amounting to ¥10,919,310.34, due to increased foreign exchange gains[8] - The company incurred research and development expenses of ¥4,468,439.35, slightly down from ¥4,752,249.59 in the previous period[17] Other Financial Metrics - The weighted average return on equity was -3.07%, an improvement of 6.34% from -9.41% in the previous year[5] - The company's short-term borrowings remained relatively stable, decreasing slightly from 1,702,088,051.28 yuan to 1,701,408,979.16 yuan[16] - The total equity of the company includes an accumulated loss of -1,921,494,543.92 yuan, reflecting ongoing financial challenges[16] - The company raised ¥291,300,000.00 through financing activities, compared to ¥376,800,000.00 in the previous period, reflecting a decrease in financing inflow[20] - Investment income for the period was ¥452,073.04, reflecting a 100% increase from the previous year due to the sale of equity in a joint venture[8]